{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T00:21:23Z","timestamp":1760833283888,"version":"build-2065373602"},"reference-count":17,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1016\/j.breast.2004.08.012","type":"journal-article","created":{"date-parts":[[2005,9,7]],"date-time":"2005-09-07T15:58:28Z","timestamp":1126108708000},"page":"399-402","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Hypercalcemia and status epilepticus relates to salmon calcitonin administration in breast cancer"],"prefix":"10.1016","volume":"14","author":[{"given":"S.Y.","family":"Chung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.H.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.L.","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.H.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.H.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.breast.2004.08.012_bib1","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0002-9343(97)80047-2","article-title":"Hypercalcemia of malignancy","volume":"103","author":"Mundy","year":"1997","journal-title":"Am J Med"},{"key":"10.1016\/j.breast.2004.08.012_bib2","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1093\/ajhp\/58.suppl_3.S4","article-title":"Overview of hypercalcemia of malignancy","volume":"58","author":"Solimando","year":"2001","journal-title":"Am J Health System Pharm"},{"key":"10.1016\/j.breast.2004.08.012_bib3","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/BF03343867","article-title":"Increased prevalence of primary hyperparathyroidism in treated breast cancer","volume":"24","author":"Fierabracci","year":"2001","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.breast.2004.08.012_bib4","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/j.1742-1241.2003.tb10597.x","article-title":"Parathyroid adenoma-related hypercalcaemia in breast cancer","volume":"57","author":"Barutca","year":"2003","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.breast.2004.08.012_bib5","first-page":"232","article-title":"Dangerous nutrition? Calcium, vitamin D, and shark cartilage nutritional supplements and cancer-related hypercalcemia","volume":"11","author":"Lagman","year":"2003","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.breast.2004.08.012_bib6","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1093\/ajhp\/58.suppl_3.S8","article-title":"Conventional treatment of hypercalcemia of malignancy","volume":"58","author":"Davidson","year":"2001","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.breast.2004.08.012_bib7","first-page":"1075","article-title":"PTHrP and breast cancer (in French)","volume":"88","author":"Devys","year":"2001","journal-title":"Bull Cancer"},{"key":"10.1016\/j.breast.2004.08.012_bib8","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/ijc.2910560323","article-title":"Cyclic AMP increases the release of parathyroid hormone-related protein from a lung-cancer cell line","volume":"56","author":"Rizzoli","year":"1994","journal-title":"Int J Cancer"},{"key":"10.1016\/j.breast.2004.08.012_bib9","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1006\/bbrc.1999.1659","article-title":"Calcitonin-suppressed expression of parathyroid hormone-related protein in breast cancer cells","volume":"265","author":"Rong","year":"1999","journal-title":"Biochem Biophy Res Commun"},{"key":"10.1016\/j.breast.2004.08.012_bib10","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1111\/j.1349-7006.1991.tb01936.x","article-title":"Effects of glucocorticoids and calcitonin on parathyroid hormone-related protein (PTHrP) gene expression and PTHrP release in human cancer cells causing humoral hypercalcemia","volume":"82","author":"Kasono","year":"1991","journal-title":"Jpn J Cancer Res"},{"key":"10.1016\/j.breast.2004.08.012_bib11","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.91.6.2115","article-title":"Cell cycle-dependent and kinase-specific regulation of the apical Na\/H exchanger and the Na,K-ATPase in the kidney cell line LLC-PK1 by calcitonin","author":"Chakraborty","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.breast.2004.08.012_bib12","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1126\/science.1847755","article-title":"Cell cycle-dependent coupling of the calcitonin receptor to different G proteins","volume":"251","author":"Chakraborty","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.breast.2004.08.012_bib13","series-title":"Principles of bone biology","first-page":"461","article-title":"The structure and molecular biology of the calcitonin receptor","author":"Goldring","year":"1996"},{"key":"10.1016\/j.breast.2004.08.012_bib14","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/0300-9629(87)90037-5","article-title":"Calcitonin induces hypercalcemia in grey mullet and immature freshwater and sea-water adapted rainbow trout","volume":"87","author":"Fouchereau-Peron","year":"1987","journal-title":"Comp Biochem Physiol A"},{"key":"10.1016\/j.breast.2004.08.012_bib15","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/0016-6480(89)90109-3","article-title":"Influence of calcitonin administration of serum calcium and inorganic phosphate level of the frog, Rana tigrina","volume":"74","author":"Srivastav","year":"1989","journal-title":"Gen Comp Endocrinol"},{"key":"10.1016\/j.breast.2004.08.012_bib16","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1210\/endo.140.5.6691","article-title":"Positive and negative regulations of the renal 25-hydroxyvitamin D3 1alpha-hydroxylase gene by parathyroid hormone, calcitonin, and 1alpha,25(OH)2D3 in intact animals","volume":"140","author":"Murayama","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.breast.2004.08.012_bib17","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1006\/bbrc.1998.9098","article-title":"The promoter of the human 25-hydroxyvitamin D3 1 alpha-hydroxylase gene confers positive and negative responsiveness to PTH, calcitonin, and 1 alpha,25(OH)2D3","volume":"249","author":"Murayama","year":"1998","journal-title":"Biochem Biophys Res Commun"}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977604001389?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977604001389?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:21:57Z","timestamp":1760775717000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960977604001389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["S0960977604001389"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2004.08.012","relation":{},"ISSN":["0960-9776"],"issn-type":[{"type":"print","value":"0960-9776"}],"subject":[],"published":{"date-parts":[[2005,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypercalcemia and status epilepticus relates to salmon calcitonin administration in breast cancer","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2004.08.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}